Loading clinical trials...
Loading clinical trials...
A Prospective Study on Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy
All patients with chronic kidney disease (stages 3, 4 and 5) and chronic dialysis patients with HCV infection attending nephrology and Hepatology OPD or getting outpatient dialysis at the dialysis unit of ILBS.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Start Date
September 1, 2015
Primary Completion Date
September 1, 2017
Completion Date
September 1, 2017
Last Updated
November 5, 2019
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions